Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
about
Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A(2A) Receptors for the Treatment of Parkinson's Disease.Molecular docking studies of 1-(substituted phenyl)-3-(naphtha [1, 2-d] thiazol-2-yl) urea/thiourea derivatives with human adenosine A(2A) receptor.Design, synthesis and anti-Parkinsonian evaluation of 3-alkyl/aryl-8-(furan-2-yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones against neuroleptic-induced catalepsy and oxidative stress in mice.Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential.
P2860
Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Neuroprotective effect of naph ...... model of Parkinson's disease.
@en
Neuroprotective effect of naph ...... model of Parkinson's disease.
@nl
type
label
Neuroprotective effect of naph ...... model of Parkinson's disease.
@en
Neuroprotective effect of naph ...... model of Parkinson's disease.
@nl
prefLabel
Neuroprotective effect of naph ...... model of Parkinson's disease.
@en
Neuroprotective effect of naph ...... model of Parkinson's disease.
@nl
P2860
P1476
Neuroprotective effect of naph ...... l model of Parkinson's disease
@en
P2093
Tarique Anwer
P2860
P304
P356
10.1080/14756360802399183
P577
2009-06-01T00:00:00Z